29.08.2013 06:30:00
|
Essilor: Publication of the 2013 Interim Financial Report
Regulatory News:
The Essilor International 2013 Interim Financial Report (Paris:EI) is being published today.
The report comprises the interim consolidated financial statements, the interim management report, the statement by the person responsible for the interim financial report and the Auditors’ review report on the interim consolidated financial statements.
It can be downloaded from the Company’s website, www.essilor.com, in the "Publications & Downloads” section, or by clicking on: http://www.essilor.com/en/Investors/Pages/PublicationsDownloads.aspx
About Essilor
The world’s leading ophthalmic optics company, Essilor designs, manufactures and markets a wide range of lenses to improve and protect eyesight. Its corporate mission is to enable everyone around the world to access lenses that meet his or her unique vision requirements. To support this mission, the Company allocates more than €150 million to research and innovation every year, in a commitment to continuously bring new, more effective products to market. Essilor’s flagship brands are Varilux®, Crizal®, Definity®, Xperio®, OptifogTM and Foster Grant®. It also develops and markets equipment, instruments and services for eyecare professionals.
Essilor reported consolidated revenue of approximately €5 billion in 2012 and employs around 50,700 people. It operates in some 100 countries with 22 plants, more than 400 prescription laboratories and edging facilities, as well as several research and development centers around the world.
For more information, please visit www.essilor.com.
The Essilor share trades on the NYSE Euronext Paris market and is included in the Euro Stoxx 50 and CAC 40 indices.
Codes and symbols: ISIN: FR0000121667; Reuters: ESSI.PA; Bloomberg: EI:FP.
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu EssilorLuxotticamehr Nachrichten
Analysen zu EssilorLuxotticamehr Analysen
02.01.25 | EssilorLuxottica Neutral | UBS AG | |
12.12.24 | EssilorLuxottica Sector Perform | RBC Capital Markets | |
12.12.24 | EssilorLuxottica Buy | Goldman Sachs Group Inc. | |
11.12.24 | EssilorLuxottica Neutral | UBS AG | |
03.12.24 | EssilorLuxottica Neutral | UBS AG |
Aktien in diesem Artikel
EssilorLuxottica | 233,10 | 1,48% |